Immunic to Participate in Scientific and Investor Conferences in July
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in July 29.06.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in July NEW YORK,...
Whether you love them or hate them, penny stocks are contentious. These tickers, which trade for less than $5 per share, have earned a reputation on Wall Street for their divisive nature, leaving investors struggling to find common ground on the matter. The appeal is clear. For the same price as one share of a more well-known company, investors can snap up hundreds of shares of a penny stock. What’s more, the fact that even minor share price appreciation can translate to irresistible percentage
Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the recipient of a large drop in short interest in May. As of May 31st, there was short interest totalling 2,330,000 shares, a drop of 28.3% from the May 15th total of 3,250,000 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is presently […]
New York-based biotechnology company Immunic Inc (NASDAQ:IMUX) has one or more potential blockbusters in its clinical pipeline. The firm’s promising lead...